A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology
Candice Roufosse, Naomi Simmonds, Marian Clahsen-van Groningen, Mark Haas, Kammi J Henriksen, Catherine Horsfield, Alexandre Loupy, Michael Mengel, Agnieszka Perkowska-Ptasińska, Marion Rabant, Lorraine C Racusen, Kim Solez, Jan U Becker, Candice Roufosse, Naomi Simmonds, Marian Clahsen-van Groningen, Mark Haas, Kammi J Henriksen, Catherine Horsfield, Alexandre Loupy, Michael Mengel, Agnieszka Perkowska-Ptasińska, Marion Rabant, Lorraine C Racusen, Kim Solez, Jan U Becker
Abstract
The Banff Classification of Allograft Pathology is an international consensus classification for the reporting of biopsies from solid organ transplants. Since its initial conception in 1991 for renal transplants, it has undergone review every 2 years, with attendant updated publications. The rapid expansion of knowledge in the field has led to numerous revisions of the classification. The resultant dispersal of relevant content makes it difficult for novices and experienced pathologists to faithfully apply the classification in routine diagnostic work and in clinical trials. This review shall provide a complete and simple illustrated reference guide of the Banff Classification of Kidney Allograft Pathology based on all publications including the 2017 update. It is intended as a concise desktop reference for pathologists and clinicians, providing definitions, Banff Lesion Scores and Banff Diagnostic Categories. An online website reference guide hosted by the Banff Foundation for Allograft Pathology (www.banfffoundation.org) is being developed, which will be updated with future refinement of the Banff Classification from 2019 onward.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
- Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993;44:411–422.
- Mengel M, Sis B, Halloran PF. SWOT analysis of Banff: strengths, weaknesses, opportunities and threats of the international Banff consensus process and classification system for renal allograft pathology. Am J Transplant. 2007;7:2221–2226.
- Becker JU, Chang A, Nickeleit V, et al. Banff borderline changes suspicious for acute T cell-mediated rejection: where do we stand? Am J Transplant. 2016;16:2654–2660.
- Solez K, Benediktsson H, Cavallo T, et al. Report of the Third Banff Conference on Allograft Pathology (July 20–24, 1995) on classification and lesion scoring in renal allograft pathology. Transplant Proc. 1996;28:441–444.
- Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int. 1999;55:713–723.
- Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant. 2004;4:1562–1566.
- Solez K, Colvin RB, Racusen LC, et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant. 2007;7:518–526.
- Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8:753–760.
- Mengel M, Sis B, Haas M, et al. Banff 2011 meeting report: new concepts in antibody-mediated rejection. Am J Transplant. 2012;12:563–570.
- Haas M, Sis B, Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant. 2014;14:272–283.
- Loupy A, Haas M, Solez K, et al. The Banff 2015 Kidney meeting report: current challenges in rejection classification and prospects for adopting molecular pathology. Am J Transplant. 2017;17:28–41.
- Haas M, Loupy A, Lefaucheur C, et al. The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18:293–307.
- Tait BD, Susal C, Gebel HM, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013;95:19–47.
- Liapis H, Gaut JP, Klein C, et al. Banff histopathological consensus criteria for preimplantation kidney biopsies. Am J Transplant. 2017;17:140–150.
- Ishii Y, Sawada T, Kubota K, et al. Loss of peritubular capillaries in the development of chronic allograft nephropathy. Transplant Proc. 2005;37:981–983.
- Farris AB, Adams CD, Brousaides N, et al. Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol. 2011;22:176–186.
- Farris AB, Chan S, Climenhaga J, et al. Banff fibrosis study: multicenter visual assessment and computerized analysis of interstitial fibrosis in kidney biopsies. Am J Transplant. 2014;14:897–907.
- Baid-Agrawal S, Farris AB, 3rd, Pascual M, et al. Overlapping pathways to transplant glomerulopathy: chronic humoral rejection, hepatitis C infection, and thrombotic microangiopathy. Kidney Int. 2011;80:879–885.
- Olson JL. Renal Disease Caused by Hypertension. In: Jennette JC, Olsen SL, Silva FG, et al., editors. Heptinstall’s Pathology of the Kidney. 7th ed Philadelphia, PA: Wolters Kluwer; 2015:849–896.
- Mengel M, Reeve J, Bunnag S, et al. Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant. 2009;9:1859–1867.
- Mannon RB, Matas AJ, Grande J, et al. Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant. 2010;10:2066–2073.
- Lefaucheur C, Gosset C, Rabant M, et al. T cell-mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts. Am J Transplant. 2018;18:377–390.
- Nankivell BJ, Shingde M, Keung KL, et al. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: the Banff i-IFTA lesion. Am J Transplant. 2018;18:364–376.
- Solez K, Fung KC, Saliba KA, et al. The bridge between transplantation and regenerative medicine: beginning a new Banff classification of tissue engineering pathology. Am J Transplant. 2018;18:321–327.
- Solez K. Kim Solez, Edmonton, Alberta, Canada Banff: a unique start setting standards for consensus conferences. Transplantation. 2017;101:2264–2266.
- Al-Awqati Q, Oliver JA. Stem cells in the kidney. Kidney Int. 2002;61:387–395.
- Stubbington MJT, Rozenblatt-Rosen O, Regev A, et al. Single-cell transcriptomics to explore the immune system in health and disease. Science. 2017;358:58–63.
- Rozenblatt-Rosen O, Stubbington MJT, Regev A, et al. The Human Cell Atlas: from vision to reality. Nature. 2017;550:451–453.
- Regev A, Teichmann SA, Lander ES, et al. The Human Cell Atlas. Elife. 2017;6 doi:10.7554/eLife.27041.
Source: PubMed